A study investigated an Immunoscore system that assessed the density of CD3+, CD8+, and PD-L1 in the epithelial and stromal compartments of the tumor center (CT) and IM in 153 patients with MSI-H GC. This evidence concerns the gene CD8A and neoplasm.